Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-23-057552

Options or other derivatives

  • Director acquired 69,186 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LAPPE RODNEY W Director 2023-12-01 Grant or award · Stock Option (right to buy) +69,186 69,186 D: show line 1 in the form
Loading xslF345X05/doc4.xml…